AbbVie’s Tavapadon Demonstrates Efficacy In Parkinson’s Monotherapy Study

 
• By Joseph Haas
  
AbbVie exterior
AbbVie is looking to treat early-stage Parkinson's with tavapadon • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D